Tag: report

ANDOVER, Mass., July 22, 2025 (GLOBE NEWSWIRE) -- Vicor Corporation (NASDAQ: VICR) today reported financial results for the second quarter ended June 30, 2025. These results will be discussed later today at 5:00 p.m. Eastern Time, during management’s quarterly investor conference call. The details for the call are below.

Conference Call to Discuss Results Scheduled for July 30th, 2025

BOSTON, July 22, 2025 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Tuesday, August 5, 2025 to report its second quarter 2025 financial results and provide a corporate update.

[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Plant Tissue Culture Market size & share revenue was valued at approximately USD 525.98 Million in 2024 and is expected to reach USD 570.61 Million in 2025 and is expected to reach around USD 1,205.94 Million by 2034, at a CAGR of 8.67% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are Phytoclone Inc., Melford Laboratories, Lifesible, Labland Biotech Private Limited, Knight Hollow Nursery, IribovSBW, HIMEDIA LABORATORIES, DP-Deroose Plants, Dark Heart Nursery, Caisson Laboratories, Inc., Booms Pharm, Alpha Laboratories, AgriStarts, AgriForest Bio-Technologies, 3 Rivers Biotech and others.

Transaction in Own Shares

QUAKERTOWN, Pa., July 22, 2025 (GLOBE NEWSWIRE) -- QNB Corp. (the “Company” or “QNB”) (OTCQX: QNBC), the parent company of QNB Bank (the “Bank”), reported net income for the second quarter of 2025 of $3,883,000 or $1.04 per share on a diluted basis. This compares to net income of $2,465,000, or $0.67 per share on a diluted basis, for the same period in 2024. For the six months ended June 30, 2025, QNB reported net income of $6,461,000, or $1.74 per share on a diluted basis. This compares to net income of $5,059,000, or $1.38 per share on a diluted basis, reported for the same period in 2024.

Explore the future of the Germany IVD Analyzers market with our comprehensive report, covering key data from 2018 to 2033. Analyze segments like Hematology, PCR Systems, and POC Analyzers. Create winning strategies, understand market dynamics, and seize growth opportunities. Ideal for strategy development.